Nektar Stops Clinical Trials For Key Cancer Drug, Shares Tumble

Nektar Stops Clinical Trials For Key Cancer Drug, Shares Tumble

(Reuters) – Nektar Therapeutics said on Thursday it had stopped all trials involving its key cancer drug following its failure in multiple studies, dragging the drug developer’s shares down 23% in after-market trading. The trials that Nektar stopped included those involving a combination of its drug bempegaldesleukin with Bristol Myers Squibb Co’s cancer drug Opdivo as…

Read More

News publisher Lee faces renewed pressure from hedge funds

OMAHA, Neb. (AP) — Newspaper publisher Lee Enterprises is facing renewed pressure from a hedge fund to speed up its transition to digital publishing and consider adding new digital-savvy leaders to its board after successfully fighting off a hostile takeover from a different hedge fund. Lee’s largest shareholder, Cannell Capital, this week disclosed buying nearly…

Read More
Chile Faces Pressure To Increase Spending Despite High Inflation, Bank Of America Says

Chile Faces Pressure To Increase Spending Despite High Inflation, Bank Of America Says

SANTIAGO (Reuters) – Chilean President Gabriel Boric faces an economic slowdown and high inflation, which conflicts with his goal to expand social programs, and could increase pressure for more financial stimulus, according to a Bank of America report released on Thursday. The government recently announced a $3.7 billion economic recovery plan to support sectors still…

Read More